Back
Akebia Therapeutics Stock Price Chart
Elon's Secret "A.I. 2.0" Project
Click here now to discover how to claim a stake in Elon's "A.I. 2.0" project
Buy
59
AKBA
Akebia Therapeutics
Last Price:
1.35
Seasonality Move:
2.81%
7 Day Trial
ALL ACCESS PASS
$
7
This DeFi Coin Could 10x Soon... I Advise You Get In Now!
Discover this DeFi diamond before the next surge- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKBA is experiencing selling pressure, which indicates risk of future bearish movement.
Akebia Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.34 | Buy |
| 20-day SMA: | 1.38 | Buy |
| 50-day SMA: | 1.56 | Sell |
| 200-day SMA: | 1.33 | Buy |
| 8-day EMA: | 1.37 | Buy |
| 20-day EMA: | 1.41 | Sell |
| 50-day EMA: | 1.48 | Sell |
| 200-day EMA: | 1.33 | Buy |
Akebia Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 46.92 | Sell |
| Chaikin Money Flow: | -3526982 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.32 - 1.5) | Sell |
| Bollinger Bands (100): | (1.28 - 1.72) | Sell |
Akebia Therapeutics Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Akebia Therapeutics Stock
Is Akebia Therapeutics Stock a Buy?
- Akebia Therapeutics share price is 1.39 while AKBA 8-day simple moving average is 1.34, which is a Buy signal.
- The stock price of AKBA is 1.39 while Akebia Therapeutics 20-day SMA is 1.38, which makes it a Buy.
- Akebia Therapeutics 50-day simple moving average is 1.56 while AKBA share price is 1.39, making it a Sell technically.
- AKBA stock price is 1.39 and Akebia Therapeutics 200-day simple moving average is 1.33, creating a Buy signal.
AKBA Technical Analysis vs Fundamental Analysis
Buy
59
Akebia Therapeutics (AKBA)
is a Buy
Is Akebia Therapeutics a Buy or a Sell?
-
Akebia Therapeutics stock is rated a Buy
The current Akebia Therapeutics [AKBA] share price is $1.39. The Score for AKBA is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
Akebia Therapeutics Stock Info
Market Cap:
291.34M
Price in USD:
1.39
Share Volume:
3.97M
Akebia Therapeutics 52-Week Range
52-Week High:
2.48
52-Week Low:
0.78
Buy
59
Akebia Therapeutics (AKBA)
is a Buy
Akebia Therapeutics Share Price Forecast
-
What is the Akebia Therapeutics stock price today?
The Akebia Therapeutics stock price is 1.39 USD today. -
Will AKBA stock go up or go down?
Akebia Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Akebia Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akebia Therapeutics is not overvalued.
Is Akebia Therapeutics Stock a Buy?
- Akebia Therapeutics share price is 1.39 while AKBA 8-day exponential moving average is 1.37, which is a Buy signal.
- The stock price of AKBA is 1.39 while Akebia Therapeutics 20-day EMA is 1.41, which makes it a Sell.
- Akebia Therapeutics 50-day exponential moving average is 1.48 while AKBA share price is 1.39, making it a Sell technically.
- AKBA stock price is 1.39 and Akebia Therapeutics 200-day simple moving average is 1.33, creating a Buy signal.
Fundamental Analysis of Akebia Therapeutics
Is Akebia Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, an increase next quarter of $0.10 per share, an increase this year of $0.05 per share, and an increase next year of $0.05 per share.
Technical Analysis of Akebia Therapeutics
Should I short Akebia Therapeutics stock?
- AKBA Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting Akebia Therapeutics is a Sell
- Akebia Therapeutics Relative Strength Index (RSI) is 46.92, which suggest Akebia Therapeutics is oversold
- The Bollinger Bands (25) for Akebia Therapeutics is (1.32 - 1.5), which suggest Akebia Therapeutics is a Sell
- The Bollinger Bands (100) for Akebia Therapeutics is (1.28 - 1.72), which suggest Akebia Therapeutics is a Sell
* Akebia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.